These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases. Swierz MJ; Storman D; Riemsma RP; Wolff R; Mitus JW; Pedziwiatr M; Kleijnen J; Bala MM Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009498. PubMed ID: 32163181 [TBL] [Abstract][Full Text] [Related]
11. Transarterial chemoembolization for pulmonary or mediastinal metastases from hepatocellular carcinoma. Hori A; Ohira R; Nakamura T; Kimura Y; Ueda S; Torii M; Kennoki N; Hori S Br J Radiol; 2020 Jun; 93(1110):20190407. PubMed ID: 32142364 [TBL] [Abstract][Full Text] [Related]
12. Role of yttrium-90 in the management of unresectable hepatocellular carcinoma and hepatic metastases. Kousik V; Promila P; Verma R; Gupta A Indian J Gastroenterol; 2016 May; 35(3):179-85. PubMed ID: 27185180 [TBL] [Abstract][Full Text] [Related]
13. Initial experience with repetitive transarterial chemoembolization (TACE) as a third line treatment of ovarian cancer metastasis to the liver: indications, outcomes and role in patient's management. Vogl TJ; Naguib NN; Lehnert T; Nour-Eldin NE; Eichler K; Zangos S; Gruber-Rouh T Gynecol Oncol; 2012 Feb; 124(2):225-9. PubMed ID: 22079359 [TBL] [Abstract][Full Text] [Related]
14. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma. Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905 [TBL] [Abstract][Full Text] [Related]
15. Simultaneous multitarget irradiation using helical tomotherapy for advanced hepatocellular carcinoma with multiple extrahepatic metastases. Jang JW; Kay CS; You CR; Kim CW; Bae SH; Choi JY; Yoon SK; Han CW; Jung HS; Choi IB Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):412-8. PubMed ID: 18963538 [TBL] [Abstract][Full Text] [Related]
16. Transarterial chemoembolization (TACE) with mitomycin C and gemcitabine for liver metastases in breast cancer. Vogl TJ; Naguib NN; Nour-Eldin NE; Eichler K; Zangos S; Gruber-Rouh T Eur Radiol; 2010 Jan; 20(1):173-80. PubMed ID: 19657653 [TBL] [Abstract][Full Text] [Related]
17. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis. Takayasu K; Arii S; Ikai I; Kudo M; Matsuyama Y; Kojiro M; Makuuchi M; AJR Am J Roentgenol; 2010 Mar; 194(3):830-7. PubMed ID: 20173167 [TBL] [Abstract][Full Text] [Related]
18. A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead. Poon RT; Tso WK; Pang RW; Ng KK; Woo R; Tai KS; Fan ST Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1100-8. PubMed ID: 17627902 [TBL] [Abstract][Full Text] [Related]
19. Transarterial chemoembolization of unresectable systemic chemotherapy-refractory liver metastases from colorectal cancer: long-term results over a 10-year period. Gruber-Rouh T; Naguib NN; Eichler K; Ackermann H; Zangos S; Trojan J; Beeres M; Harth M; Schulz B; Nour-Eldin A NE; Vogl TJ Int J Cancer; 2014 Mar; 134(5):1225-31. PubMed ID: 23960002 [TBL] [Abstract][Full Text] [Related]
20. Chemoembolization with drug eluting beads preloaded with irinotecan (DEBIRI) vs doxorubicin (DEBDOX) as a second line treatment for liver metastases from cholangiocarcinoma: a preliminary study. Venturini M; Sallemi C; Agostini G; Marra P; Cereda S; Reni M; Aldrighetti L; De Cobelli F; Del Maschio A Br J Radiol; 2016 Nov; 89(1067):20160247. PubMed ID: 27558984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]